The Department of Neurology is actively involved in clinical and basic science research.
Studies on new therapies are currently underway in stroke, multiple sclerosis, Parkinson's Disease and epilepsy. These studies may help establish the effectiveness of new therapies or help identify better treatments for neurologic diseases. If you are a patient interested in participating in a study, please contact Ms. Renay Drinkard at (251) 660-5121 or firstname.lastname@example.org.
STUDIES CURRENTLY ENROLLING PARTICIPANTSEpilepsy
1. Antiepileptic drug study for children with epilepsy
Antiepileptic drug study in children to measure the safety, tolerability and pharmacokinetics of an oral seizure medication in pediatric patients 1 month through 16 years of age with partial onset seizures.
2. New antiepileptic drug for uncontrolled epilepsy
Antiepileptic drug study for patients aged 16 to 70 years with partial onset seizures not well controlled by current antiepileptic drugs.
3. New antiepileptic drug formulation for children with epilepsy
Antiepileptic drug study in children 12 to 16 years old and adults 18 to 55 years old with epilepsy to evaluate a new formulation of an epileptic medication for safety and tolerability.
1. Stroke prevention study (NIH)
Stroke prevention study to define effective therapies for prevention of stroke recurrence in small strokes. Potential candidates are patients 30 years of age and older with a diagnosis of stroke within the past 6 months.
2. Reduction of insulin resistance in stroke prevention (NIH)
Stroke prevention study to test the effectiveness of an agent that reduces insulin resistance, for reducing the risk for stroke or MI among patients with a recent stroke or TIA and insulin resistance. Potential candidates are patients 45 years or greater with ischemic stroke or TIA within 6 months.